Skip to main content

Tag: THCA

The New Enforcement-Industrial Complex: From Nixon’s War on Drugs to Texas SB 3

In 1961, President Dwight D. Eisenhower warned the nation of a growing danger:

“In the councils of government, we must guard against the acquisition of unwarranted influence, whether sought or unsought, by the military-industrial complex.”

He was speaking of the dangerous entanglement between government and defense contractors—an alliance that risked turning war into an economic necessity. But Eisenhower’s words apply just as powerfully to another, quieter behemoth that emerged within our borders over the decades: the enforcement-industrial complex—a system built not on defending national security, but on policing and punishing domestic populations.

This sprawling network of police unions, private prison operators, surveillance companies, drug testing firms, and aligned legislators has, for decades, thrived on one thing: the criminalization of human behavior. Most notably, it has flourished under the banner of the War on Drugs—a campaign that has devastated communities, cost taxpayers billions, and produced little measurable public safety or public health benefit.

And now, in Texas, it’s reasserting itself through Senate Bill 3 (SB 3)a sweeping ban on consumable hemp-derived THC products like Delta-8, Delta-10, and even hemp-based Delta-9. If passed, SB 3 would not only erase a thriving, consumer-driven industry—it would reignite a failed model of prohibition and control, wrapped in new political packaging.

 

 

From the War on Drugs to the Politics of Control

The foundation of America’s modern drug policy was laid during the Nixon administration with the passage of the Controlled Substances Act (CSA) of 1970, which created the federal drug scheduling system still in use today. Despite recommendations from experts to treat cannabis as a low-risk substance, Nixon’s administration deliberately placed it in Schedule I—alongside heroin—declaring it had “no accepted medical use” and a high potential for abuse. This move was not grounded in science, but in politics.

This legal framework helped spawn the Drug Enforcement Administration (DEA) and ushered in a new era of militarized policing, mass incarceration, and stigma-driven policy. SB 3 in Texas is a direct descendant of this legacy: it seeks to criminalize legal, hemp-derived cannabinoids using the same fear-based rhetoric and enforcement-first logic, despite widespread public use, minimal harm data, and clear economic benefit. It represents a return to prohibitionist policymaking—rooted in control, not public health.

The mythos of the War on Drugs has long claimed that harsh penalties and aggressive enforcement were necessary to protect Americans from the scourge of addiction. But internal admissions from key figures have exposed a far different reality.

In a 1994 interview, John Ehrlichman, a top domestic advisor to President Richard Nixon, admitted:

“The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and Black people… By getting the public to associate the hippies with marijuana and Blacks with heroin, and then criminalizing both heavily, we could disrupt those communities.”

What Ehrlichman revealed was not policy—it was strategy. Criminalization was weaponized for political ends: to break up organizing power, discredit opposition, and institutionalize social control. The resulting machinery—fueled by fear, racism, and misinformation—continues to operate today under new pretenses.

Texas’s SB 3 is not a break from that legacy. It is an extension of it.

SB 3: The Return of Reefer Madness

SB 3 seeks to criminalize the manufacture, sale, and possession of virtually all hemp-derived cannabinoid products that contain anything beyond CBD or CBG. This includes compounds like Delta-8 THC, which are already regulated under Texas’s existing hemp laws and widely used by veterans, cancer patients, and ordinary Texans seeking relief from anxiety, pain, and insomnia.

Supporters of SB 3 argue that these products pose a danger to youth and public safety. But their evidence is shockingly thin.

During legislative hearings, Allen Police Chief Steve Dye declared that these products are “poisoning our kids.” Yet neither he nor other supporters offered any credible data—no Department of Health reports, no emergency room spikes, no controlled studies. Instead, they relied on anecdotes and sensational headlines.

This kind of rhetoric—unsubstantiated, emotional, and politically convenient—is Reefer Madness reincarnated. And like the original, it obscures far more than it reveals.

 

 

The Role of Law Enforcement: Interests Over Integrity

 

SB 3 has received heavy backing from police associations, prosecutors, and law enforcement lobbyists. That alone should raise questions. Who benefits from the recriminalization of legal products?

The answer is clear: police departments gain new enforcement powersjail populations growdrug testing firms profit, and court systems collect more fines and fees. In short, the entire enforcement-industrial complex stands to profit—just as it always has when new crimes are created.

This isn’t public safety policy. It’s institutional self-preservation. It’s prohibition repackaged for 2025.

 

 

Medical Marijuana: A Convenient Shield

Proponents of SB 3 often argue that Texans who need cannabis for medical reasons can simply go through the state’s Compassionate Use Program (CUP). On the surface, this seems like a reasonable alternative. But in reality, CUP is inaccessible, inadequate, and deeply monopolistic.

 

  • Only a tiny fraction of Texans qualify under CUP’s narrow medical eligibility list.
  • The products are expensivelow in THC, and less effective than widely available hemp alternatives.
  • Only three companies currently hold licenses to grow and sell cannabis under CUP—licenses that are extremely valuable and tightly guarded.

If SB 3 passes, it will eliminate hemp-derived alternatives that have helped thousands of Texans manage pain, trauma, and illness—leaving only a state-sanctioned oligopoly to serve a small, privileged market.

This isn’t regulation. It’s market capture.

 

Two Legal Systems, One Plant

If SB 3 becomes law, Texas will establish two entirely different legal frameworks for the exact same compound:

Hemp-Derived THC CUP-Derived Medical Marijuana
Grown and processed under 2019 Texas hemp law Licensed under strict state program
Sold at independent, small businesses Sold by a few state-authorized companies
Used by veterans, seniors, cancer patients Available to select patients only
At risk of being banned under SB 3 Protected under existing medical cannabis law

This isn’t about chemistry. It’s about who profits—and who is punished.

 

 

Prohibition 2.0: Greenwashed, Institutionalized, and Still Failing

Eisenhower warned that entrenched interests would distort democracy and hijack public policy for their own ends. The military-industrial complex he named has been joined by a domestic counterpart—one that builds power not through conflict abroad, but through enforcement at home.

SB 3 is not a policy rooted in science or safety. It is a political maneuver designed to restore criminalization, protect monopolies, and entrench a set of institutions that benefit from punishment over care.

The victims—again—will be working-class people, patients, small business owners, and communities of color. The beneficiaries will be those who already hold economic and institutional power.

“Nixon’s War On Drugs”

 

A Test of Texas Values

At its core, SB 3 is a moral question disguised as a legislative proposal. Do we believe in evidence-based policy, small business freedom, personal autonomy, and the right to choose non-addictive alternatives to pharmaceuticals? Or do we believe in fear-based control, criminal punishment, and economic protectionism?

We cannot continue to criminalize plant-based compounds while ignoring alcohol-related deaths, skyrocketing fentanyl overdoses, and a failing mental health infrastructure. We cannot afford to keep reviving a failed war in the name of protecting people it never protected.

SB 3 must be seen for what it is: a reboot of the War on Drugs, disguised as reform, designed to serve prohibitionists, monopolists, and those politicians who profit from fear.

So let’s call this for what it is—Texas own version of the Deep State. The time to dismantle the enforcement-industrial complex is now. Texans deserve better.

Whitney: Economic Impact of the Texas Hemp Industry

Total Market Value: The Texas hemp-derived cannabinoid industry generates $5.5 billion annually.

• Retail Sales: The retail sector alone contributes $4.3 billion in revenue.

• Overall Economic Impact: The industry supports $10.2 billion in total economic activity.

• Tax Contributions: Hemp-derived cannabinoid sales generate $267.7 million in annual state sales tax revenue.

• Job Creation: The industry employs 53,382 workers, paying out $2.1 billion in wages.

Potential Economic Loss if SB 3 Passes

• Business Closures: Approximately 6,350 businesses would be forced to shut down.

• Job Losses: An estimated 40,201 workers would lose their jobs.

• Wage Decline: Texas workers would lose $1.6 billion in wages.

• Economic Shrinkage: A $10.2 billion reduction in economic activity.

• Tax Revenue Loss: Texas would forgo $267.7 million in annual sales tax.

 

Industry Health & Growth Trends

• Profitability93% of hemp businesses are either profitable or breaking even.

• Retail Growth: The number of registered retail locations increased from 5,072 in 2022 to 7,550 in 2024.

• Wage Increases: Average wages in retail rose from $14.19/hour in 2023 to $17.83/hour in 2025.

• Diversification: The industry has expanded beyond CBD into Delta-8, Delta-9, THCA, CBG, CBN, and HHC products.

• Texas Supply Chain: Most Texas hemp businesses source materials from multiple states but prioritize in-state suppliers.

Regulatory Uncertainty & Business Risks

• Top Business Concern: The primary risk cited by hemp businesses is state and federal regulatory changes.

• Federal Oversight: The FDA has not identified a public safety crisis related to converted cannabinoids.

• State-Level Crackdowns: States that have enacted similar restrictions, like Oregon, saw millions in lost revenue and disrupted supply chains.

Policy Recommendations

• Avoid Prohibition: Rather than banning hemp-derived cannabinoids, regulation should focus on product safety, age restrictions, and clear labeling.

• Support Economic Stability: Restricting the industry would disrupt thousands of jobs and millions in tax revenuewithout clear public safety benefits.

• Encourage Collaboration: A balanced regulatory approach could maintain public safety while allowing Texas businesses to continue growing.

80stixx – Premium Alternative Cannabinoid Products

Since its inception in 2022, 80stixx has rapidly established itself as a leader in the alternative cannabinoid market. Inspired by the Amarillo area code “806,” the brand has expanded its reach across the country, securing placement in over 1,000 stores and establishing more than 10 distribution accounts. With a focus on quality, transparency, and innovation, 80stixx is reshaping the cannabinoid landscape with its wide array of products and commitment to excellence.

 

The Journey

80stixx’s quick rise in the industry reflects its dedication to providing high-quality cannabinoid products that meet consumer demands. Drawing inspiration from its Texas roots, the brand has become a household name in alternative cannabinoids, offering everything from Delta-8 (D8) and Delta-9 (D9) products to THCA. Each product is carefully crafted to deliver purity, potency, and consistency—qualities that set 80stixx apart in a crowded marketplace.

What truly distinguishes 80stixx from other brands in the cannabinoid industry is its focus on the finer details—taste, aesthetics, and innovative packaging. The brand is known for pioneering die-cut packaging for their D8 and D9 gummies, incorporating creative designs that enhance the consumer experience. This attention to packaging not only adds a visual appeal but also signals the brand’s commitment to quality and innovation.

On the taste front, 80stixx gummies are infused with authentic flavors and precision D9 dosing, ensuring a superior experience for consumers. Unlike many other brands that spray cannabinoids onto gummies, 80stixx opts for infusion, delivering a more consistent and enjoyable product without an overpowering cannabis taste.

 

Adapting to the Shifting Legal Landscape of Hemp-Derived Cannabinoids

Operating in the alternative cannabinoid space means keeping up with the ever-evolving legal landscape. States across the U.S. have varied regulations regarding cannabinoids like THCA and Delta-8, making compliance a top priority for brands like 80stixx. The 2018 Farm Bill paved the way for the hemp industry, but ongoing legislative changes require companies to stay vigilant.

Recently, 80stixx faced challenges in Florida when packaging regulations forced the temporary removal of their products from the market. However, thanks to a reversal of those laws, the company was able to quickly resume operations. This agility in navigating legal challenges demonstrates 80stixx’s resilience and commitment to maintaining a strong presence in the market.

Commitment to Transparency and Lab Testing

Quality and transparency are at the heart of 80stixx’s operations. The company emphasizes the importance of third-party lab testing for all its products to ensure purity, potency, and safety. Every product sold by 80stixx includes a scannable QR code, allowing customers to easily access the Certificate of Analysis (COA) for that batch. This level of transparency not only builds trust with consumers but also ensures that 80stixx continues to deliver the highest standards of cannabinoid products.

 

Emerging Trends and Innovations Shaping the Future of 80stixx

As the cannabinoid industry grows, consumer preferences are shifting, and 80stixx is keeping pace with the latest trends. One emerging trend is the popularity of diamond prerolls, a product that has been gaining traction among retail outlets. 80stixx plans to expand its product line to include more offerings in this category, capitalizing on the growing demand for premium prerolls.

Another notable trend is the increasing interest in edibles and beverages, particularly among an older demographic. While younger consumers tend to favor flower products from smoke shops, edibles are becoming more popular as a discreet and convenient way to consume cannabinoids. 80stixx is well-positioned to cater to both segments, offering a diverse range of products to meet varying consumer needs.

 

Sustainability: A Key Priority

Sustainability is a growing concern in the hemp and cannabinoid industries, and 80stixx is committed to doing its part. The company works closely with growers and manufacturers to ensure that all operations are environmentally responsible. Regular visits to production facilities and optimized shipping processes help 80stixx minimize its environmental impact, even in challenging conditions such as extreme heat.

This focus on sustainability not only benefits the environment but also aligns with the values of many of 80stixx’s customers, who are increasingly seeking eco-friendly products.

 

Shaping the Future of the Hemp Industry

As a rising force in Texas’ hemp and cannabinoid industry, 80stixx is committed to playing a leading role in shaping the future of this rapidly growing sector. The company aims to be a major producer and influencer, crafting innovative solutions and advocating for favorable legislation that supports the growth of the hemp industry.

Looking ahead, 80stixx has its sights set on offering legal cannabinoid products in dispensaries nationwide. With its strong focus on quality, transparency, and sustainability, the brand is poised to continue leading the way in the cannabinoid market for years to come.

For more information about 80stixx and its range of cannabinoid products, visit 80stixx.com or contact them at:

Address: 300 W 6th Street Suite #127, Borger, Texas 79007

Phone: +1 (806) 553-7875

Email: [email protected]

80stixx remains dedicated to offering high-quality, lab-tested cannabinoid products, bringing transparency and innovation to an evolving industry.

THCa Continues to Make Waves in The Texas Cannabis Landscape

THCa, which stands for tetrahydrocannabinoilic acid, is a non-psychoactive cannabinoid that is the precursor to the well-known psychoactive cannabinoid, THC. Through a process called decarboxylation, THCa converts to THC. 

According to Wyatt Larew, founder of the Dallas-based cannabis brand Wyatt Purp, decarboxylation happens when the plant is exposed to light, heat and death. 

“The scientific definition of THCa is conventional cannabis that has not converted into THC yet,” he said. 

When live plants are tested, Larew said the THC content will be higher in the same plant four to six weeks post-harvest.

“That’s because decomposition is decarboxylation,” he said. 

According to Larew, the U.S. Drug Enforcement Agency deems THCa flower legally compliant hemp flower because testing takes place before decarboxylation occurs. 

“All THCa flower is federally legal cannabis. There’s no difference in it other than the time of the testing,” Larew said. “The U.S. Department of Agriculture doesn’t regulate finished goods, and everything is done with a full chain of custody from the farm to the package. The testing was done while it was like that.”

By this logic, Larew says all cannabis is technically federally legal.

“This has been legal since 2018, which means that every single cannabis arrest since 2018 is based off of constitutional fraud,” he said.

According to Larew, it gets dicey when Texas’ state crime labs test products that were purchased as legal THCa because they could have since decarboxylated through the natural decomposition process. He also said a common testing method called gas chromatography uses heat, which also causes decarboxylation. 

In a Feb. 14, 2023, letter regarding the legal status of THCa in smokable hemp, Rod Kight of Kight Law Group LLP acknowledges that there are dozens of forms of the THC molecule, including THCa, but only delta-9 THC is used to determine whether harvested hemp and hemp products are lawful under federal law. 

“The quantity and concentration of other THC isomers, and other cannabinoids and forms of THC, including THCa, are totally irrelevant with respect to the legal status of harvested hemp and hemp products,” the letter states. 

Unlocking THCa’s Health Benefits

While THCa does not offer psychoactive effects, it has been shown to offer some health benefits. According to Cresco Labs, one of the largest publicly traded, vertically integrated multistate cannabis companies in the U.S., THCa is beneficial for relieving inflammation and pain and is an ideal cannabinoid for relieving the symptoms of arthritis and seizures. It’s also an effective neuroprotectant, they say, making it beneficial for the treatment of multiple sclerosis, Alzheimer’s and Parkinson’s disease. 

Because of decarboxylation, however, users must consume the plant in a certain way to reap the health benefits of THCa. When smoking cannabis, the heat converts THCa into THC, so it’s best to grind fresh flower into something edible.

Arbors Wellness, a Michigan-based medical marijuana provisioning center, recommends sourcing a freshly made THCa extract or adding ground bud into a smoothie along with other superfoods like kale or avocado. 

“Some people even juice fresh palm leaves and sugar leaves right after harvest, but make sure your grower isn’t using chemical pesticides if you’re planning this,” the Arbors Wellness blog states. 

Building an Empire with THCa

Wyatt Purp has become a major player in the THCa landscape, and Larew said the company has experienced a 10,000% annual year-over-year growth rate since 2021. Up to this point, Larew has shipped his THCa flower to customers nationwide through his e-commerce store. However, he said a Wyatt Purp retail store is coming in the next couple of months. 

“We don’t have a location decided yet, but I’m just getting my ducks in a row and waiting to pull the trigger,” he said. 

Larew said his stores will not offer the typical smoke shop experience but will operate more like cannabis dispensaries in legal states. The locations will not sell nicotine products, and patrons will first check-in in a waiting room before going to the back to select natural THCa flower from the menu. 

Larew said he plans to open multiple Wyatt Purp stores, with the flagship brick-and-mortar location planned for Dallas.